Description:
Home Page: www.bms.com
430 East 29th Street
New York,
NY
10016
United States
Phone:
212 546 4000
Officers
| Name | Title |
|---|---|
| Dr. Giovanni Caforio M.D. | Chairman & CEO |
| Mr. David V. Elkins | Exec. VP & CFO |
| Ms. Sandra Leung Esq. | Exec. VP & Gen. Counsel |
| Dr. Christopher S. Boerner | Exec. VP & Chief Commercialization Officer |
| Mr. Rupert Vessey BCH, BM, DPHIL, M.A. | Exec. VP and Pres of Research & Early Devel. |
| Mr. Greg Meyers | Exec. VP and Chief Digital & Technology Officer |
| Mr. Timothy Power | VP & Head of Investor Relations |
| Ms. Cari Gallman | Sr. VP & Chief Compliance and Ethics Officer |
| Ms. Ann M. Powell Judge | Exec. VP & Chief HR Officer |
| Mr. Jitendra Tyagi | Head of US Drug Makers - India |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 6.8681 |
|---|---|
| Trailing PE: | 13.0016 |
| Price-to-Book MRQ: | 3.5929 |
| Price-to-Sales TTM: | 11.2979 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 34300 |